Press release distribution to media in EMEA
  • Middle East
  • North Africa
  • Global
  • Business
  • Finance
  • Technology
  • Press
  • About Us
    • Press Release Distribution Services
    • Submit Press Release
    • Contact Us
Submit PR
No Result
View All Result
MENA NEWS | Press release distribution to media in UAE and MENA regions
  • Middle East
  • North Africa
  • Global
  • Business
  • Finance
  • Technology
  • Press
  • About Us
    • Press Release Distribution Services
    • Submit Press Release
    • Contact Us
Submit PR
No Result
View All Result
PR distribution to media in EMEA
Submit PR
Home Press

Emerging markets offer lucrative opportunities

admin by admin
January 15, 2022
in Press
Emerging markets offer lucrative opportunities
Share on FacebookShare on Twitter


 


(EMAILWIRE.COM, January 13, 2022 ) This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global biologics safety testing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects.

According to the new market research report “Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Application (Vaccine, Monoclonal Antibodies, Blood products, Cell & Gene Therapy Products), Test Type (Endotoxin, Myoplasm, Sterility Test) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period.

The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments. In addition, emerging markets and increasing biopharmaceutical outsourcing are expected to provide significant growth opportunities for players in the Biologics safety testing market.

Browse in-depth TOC on “Biologics Safety Testing Market”

142 – Tables

42 – Figures

185 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144

The growth of the global biologics safety market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments.

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic. The World Health Organization (WHO) officially declared the outbreak of COVID-19 a pandemic. A mix of established pharmaceutical and biopharmaceutical companies, along with the players of the Biologics safety testing market, have stepped forward to contribute to worldwide research efforts by providing biologics safety testing for developing safety test kits and testing for treatments and vaccines manufacturing that target the infection caused by the novel Coronavirus.

The residual host-cell proteins and DNA detection tests segment accounted for the largest share of the Biologics Safety Testing market in 2020.

Based on test type, the market is segmented into residual host-cell proteins and DNA detection tests, endotoxin tests, sterility tests, mycoplasma tests, bioburden tests, and virus safety tests. In 2020, the residual host-cell proteins and DNA detection tests segment accounted for the largest market share. The rising demand for residual HCP and DNA detection tests for recombinant proteins and increasing focus on the quality of drugs are the major factors driving the growth of this segment.

The monoclonal antibodies manufacturing segment accounted for the largest market share of the market in 2020.

Based on application, the biologics safety testing market is segmented into monoclonal antibodies manufacturing, vaccines manufacturing, blood and blood products manufacturing, cellular and gene therapy products manufacturing, and other applications. In 2020, the monoclonal antibodies manufacturing segment accounted for the largest market share. The large share of this segment can be attributed to the rising prevalence of diseases and increasing government initiatives for the development of monoclonal antibody drugs.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=34624144

The Asia Pacific region is the fastest growing region of the Biologics safety testing market in 2020.

The Asia Pacific market is projected to witness the highest growth rate during the forecast period, primarily due to the expansion of key market players in emerging Asia Pacific countries, increasing expenditure on life science research, and the increasing trend of pharmaceutical outsourcing to Asia Pacific countries.

Prominent players in the biologics safety testing market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), and Eurofins Scientific (Luxembourg). The key players in this market are focusing on strategic expansions, partnerships, and product launches and approvals to expand their presence in the market.

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Browse Related Reports:

Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs), Region – Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/mycoplasma-testing-market-136509856.html

Pyrogen Testing Market by Product & Service (Assays, Kits, Reagents, Instruments, Services), Test Type (LAL, Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit), End User (Pharmaceutical, Biotechnology, Medical Device), Region – Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/pyrogen-testing-market-255266155.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/biologics-safety-testing-market.asp

Visit Our Web Site: https://www.marketsandmarkets.com

Content Source: https://www.marketsandmarkets.com/PressReleases/biologics-safety-testing.asp



Source link

Previous Post

The food & agriculture packaging end-use industry is expected to be the largest consumer of thermoforming plastic, globally

Next Post

Leukapheresis Market worth $91 million

RelatedPosts

Press

Lighting Transformer Market to reach USD 3 Bn by 2029, emerging at a CAGR of 5.4 percent and forecast (2023-2029)

(EMAILWIRE.COM, May 29, 2023 ) The total global market for the “Lighting Transformer Market” was valued at USD...

by admin
May 29, 2023
Press

Conventional Oil Market to reach USD 3493.71 Bn by 2029, emerging at a CAGR of 3.8 percent and forecast (2023-2029)

(EMAILWIRE.COM, May 29, 2023 ) The total global market for the “Conventional Oil Market” was valued at USD...

by admin
May 29, 2023
Press

Identity Verification Market Size, Share, Growth, Trends and Forecast – 2027

(EMAILWIRE.COM, May 29, 2023 ) According to a research report "Identity Verification Market by Component (Solutions and Services),...

by admin
May 29, 2023
Press

Latin America: Opportunities and Challenges in On-Orbit Satellite Servicing (2023-2030)

(EMAILWIRE.COM, May 29, 2023 ) This report analyses the On-orbit Satellite Servicing Market from 2023 to 2030. It...

by admin
May 29, 2023
Load More

Advertize

Latest Post

Prioritizing the U.S.-Africa Commercial Agenda

Prioritizing the U.S.-Africa Commercial Agenda

by admin
May 31, 2023

Neutrino Energy: استكشاف الإمكانات غير المستغلة لطاقة النيوترينو

Neutrino Energy: استكشاف الإمكانات غير المستغلة لطاقة النيوترينو

by admin
May 31, 2023

الرياض تستضيف فعاليات الدورة الثانية من المنتدى العالمي لإدارة المشاريع

الرياض تستضيف فعاليات الدورة الثانية من المنتدى العالمي لإدارة المشاريع

by admin
May 31, 2023

الرياض تستضيف فعاليات الدورة الثانية من المنتدى العالمي لإدارة المشاريع

Riyadh hosts second edition of Global Project Management Forum

by admin
May 31, 2023

Rising Confidence and Strong Performance: Hercules Capital Inc. Attracts Institutional Investors and Boosts Dividend Payout

Rising Confidence and Strong Performance: Hercules Capital Inc. Attracts Institutional Investors and Boosts Dividend Payout

by admin
May 31, 2023

AND BEYOND: A new era of Production and Digital Engagement with Marwan Khoury

AND BEYOND: A new era of Production and Digital Engagement with Marwan Khoury

by admin
May 29, 2023

MENANEWS provides press release distribution services for businesses, organizations and other entities with the need to reach media outlets in Europe, Middle east and Africa (MENANEWS) Submit press release or contact us today.

Share Us

CATEGORIES

MIDDLE EAST
NORTH AFRICA
GLOBAL
BUSINESS
FINANCE
TECHNOLOGY
PRESS

Subscribe To Our Newslatter

    © 2023 Copyright MENANEWS.CLUB
    No Result
    View All Result
    • Middle East
    • North Africa
    • Global
    • Business
    • Finance
    • Technology
    • Press
    • About Us
      • Press Release Distribution Services
      • Submit Press Release
      • Contact Us

    © Copyright MenaNews.club™